BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anna Angelousi, Gregory Kaltsas, Anna Koumarianou, Martin O. Weickert, Ashley Grossman. Chemotherapy in NETs: When and howReviews in Endocrine and Metabolic Disorders 2017; 18(4): 485 doi: 10.1007/s11154-017-9432-1
2
Francesco Tonelli, Francesca Marini, Francesca Giusti, Maria Luisa Brandi. Gastro-entero-pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: a therapy updateInternational Journal of Endocrine Oncology 2017; 4(1): 43 doi: 10.2217/ije-2016-0017
3
Silvia Martina Ferrari, Marco Centanni, Camilla Virili, Mario Miccoli, Paola Ferrari, Ilaria Ruffilli, Francesca Ragusa, Alessandro Antonelli, Poupak Fallahi. Sunitinib in the Treatment of Thyroid CancerCurrent Medicinal Chemistry 2019; 26(6): 963 doi: 10.2174/0929867324666171006165942
4
Martina Ferrata, Arno Schad, Stefanie Zimmer, Thomas J. Musholt, Katharina Bahr, Julian Kuenzel, Sven Becker, Erik Springer, Wilfried Roth, Matthias M. Weber, Christian Fottner. PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative ActivityFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00343
5
Anna Kathrin Stueven, Antonin Kayser, Christoph Wetz, Holger Amthauer, Alexander Wree, Frank Tacke, Bertram Wiedenmann, Christoph Roderburg, Henning Jann. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and FutureInternational Journal of Molecular Sciences 2019; 20(12): 3049 doi: 10.3390/ijms20123049
6
Konstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, Katrina R Swett, Edward A Levine, Jonathan Sham, Gary N Mann, Perry Shen. Analysis of recurrence after the resection of pancreatic neuroendocrine tumorsJournal of Surgical Oncology 2018; 118(3): 416 doi: 10.1002/jso.25146
7
Pengchen Chen, Qingshui Wang, Jianwei Xie, Hang Fai Kwok. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumorsSeminars in Cancer Biology 2019; 58: 80 doi: 10.1016/j.semcancer.2019.04.005
8
Shan Wu, Jianjun Zhou, Jing Guo, Zhan Hua, Jianchen Li, Zai Wang. Apatinib inhibits tumor growth and angiogenesis in PNET modelsEndocrine Connections 2019; : 8 doi: 10.1530/EC-18-0397
9
Jasmine Shell, Xavier M Keutgen, Corina Millo, Naris Nilubol, Dhaval Patel, Samira Sadowski, Myriem Boufraqech, Lily Yang, Roxanne Merkel, Christine Atallah, Peter Herscovitch, Electron Kebebew. 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumorInternational Journal of Endocrine Oncology 2018; 5(1): IJE04 doi: 10.2217/ije-2017-0005
10
Yulong Li, William F Simonds. Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromesInternational Journal of Endocrine Oncology 2017; 4(2): 85 doi: 10.2217/ije-2016-0018
11
N. A. Maistrenko, P. N. Romashchenko, R. V. Orlova, M. V. Lysanyuk. Possibilities of treating patients with generalized neuroendocrine tumorsOnkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(2): 16 doi: 10.17116/onkolog20187216-25
12
Hiroki Ueda, Yoshimitsu Akiyama, Shu Shimada, Kaoru Mogushi, Misaki Serizawa, Satoshi Matsumura, Yusuke Mitsunori, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Minoru Tanabe, Shinji Tanaka. Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETsEndocrine-Related Cancer 2018; 25(6): 619 doi: 10.1530/ERC-17-0328